Thynk Capital Investor

Thynk Capital, founded by Jim Plante, is focused on early-stage Therapeutics, Healthcare and Technology companies. The investment strategy has a strong focus in opportunities that have the potential of becoming an innovative break thru, a modern replacement or a complement to existing products on the market.
Industry: Biotechnology
Headquarters: United States
Founded Date: 2011
Employees Number: 1-10
Investor Type: Historical Investment Performance in Top 1% of Venture Funds. Primary focus on Longevity and defeating Diseases of Aging.
Number Of Exits: 15

Visit Website
Register and Claim Ownership